1. Home
  2. CAE vs ABVX Comparison

CAE vs ABVX Comparison

Compare CAE & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CAE Inc.

CAE

CAE Inc.

N/A

Current Price

$26.29

Market Cap

10.1B

Sector

N/A

ML Signal

N/A

Logo Abivax SA American

ABVX

Abivax SA American

N/A

Current Price

$109.97

Market Cap

9.7B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CAE
ABVX
Founded
1947
2013
Country
Canada
France
Employees
N/A
67
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
9.7B
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
CAE
ABVX
Price
$26.29
$109.97
Analyst Decision
Buy
Buy
Analyst Count
3
13
Target Price
$34.33
$130.85
AVG Volume (30 Days)
562.8K
770.7K
Earning Date
05-12-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.29
N/A
Revenue Next Year
N/A
$0.22
P/E Ratio
$35.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.36
$4.77
52 Week High
$34.24
$148.83

Technical Indicators

Market Signals
Indicator
CAE
ABVX
Relative Strength Index (RSI) 36.39 40.44
Support Level $26.14 $106.37
Resistance Level $29.71 $130.20
Average True Range (ATR) 0.84 5.27
MACD -0.15 -0.28
Stochastic Oscillator 11.30 9.74

Price Performance

Historical Comparison
CAE
ABVX

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: